LL37 (CAP-18,Cathelicidin) – 5mg per vial

Clinical Test Expectation – LL37 – Human Subjects : Antibiotic resistant infections. Immune system booster. Staphylococcus Aureus bacteria barrier. Beneficial for those who suffer with autoimmune disease, Inflammatory Bowel Disease, arthritis or Lupus.
Strength – 5MG per vial

Introduction
LL-37 is an antimicrobial peptide (AMP) that belongs to the cathelicidin family and serves as an alternative to antibiotics. An AMP can eliminate the bugs, regulate bacterial invasions, and control infections and inflammation. The peptide is naturally produced within the body through various tissues and circulates throughout different cells including bone marrow cells, epithelial cells and gastrointestinal tract cells. However, if the body doesn’t produce enough, it becomes vulnerable to bad bacteria, eventually causing it to accumulate pathogens and create chronic diseases and inflammation. Peptides contain amino acids that release certain proteins to focus on refining certain bodily functions. LL-37 contains approximately 12-80 amino acids with the purpose of assisting patients build immunity and fight contagious viruses.

Peptide LL-37 acts as the first line of defense when the body is suffering from injuries, infections, wounds or inflammation. Because of this, the peptide is useful in treating those suffering from tick-borne illnesses such as Lyme, RMSF, Anaplasmosis, Babesiosis and Colorado Tick Fever. Other research has shown that the peptide is effective in treating conditions such as diabetes, E. Coli, Candida Albicans, and certain types of cancer. While it’s mostly known for its anti-biofilm, the peptide also plays a critical role in regulating inflammatory molecules and contains healing properties to damaged tissues. This is especially beneficial for those who suffer with autoimmune disease, Inflammatory Bowel Disease, arthritis or Lupus.

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/